Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies

内科学 医学 前瞻性队列研究 队列 肿瘤科 计算机科学
作者
Teerha Piratvisuth,Jinlin Hou,Tawesak Tanwandee,Thomas Berg,Arndt Vogel,Jörg Trojan,Enrico N. De Toni,Masatoshi Kudo,Anja Eiblmaier,Hanns‐Georg Klein,Johannes Kolja Hegel,Kairat Madin,Konstantin Kroeniger,Ashish Sharma,Henry Lik‐Yuen Chan
出处
期刊:Hepatology communications [Lippincott Williams & Wilkins]
卷期号:7 (11) 被引量:18
标识
DOI:10.1097/hc9.0000000000000317
摘要

Background: Alpha-fetoprotein (AFP) and des-gamma carboxyprothrombin (DCP), also known as protein induced by vitamin K absence-II (PIVKA-II [DCP]) are biomarkers for HCC with limited diagnostic value when used in isolation. The novel GAAD algorithm is an in vitro diagnostic combining PIVKA-II (DCP) and AFP measurements, age, and gender (biological sex) to generate a semi-quantitative result. We conducted prospective studies to develop, implement, and clinically validate the GAAD algorithm for differentiating HCC (early and all-stage) and benign chronic liver disease (CLD), across disease stages and etiologies. Methods: Patients aged ≥18 years with HCC or CLD were prospectively enrolled internationally into algorithm development [n = 1084; 309 HCC cases (40.7% early-stage) and 736 controls] and clinical validation studies [n = 877; 366 HCC cases (47.6% early-stage) and 303 controls]. Serum samples were analyzed on a cobas ® e 601 analyzer. Performance was assessed using receiver operating characteristic curve analyses to calculate AUC. Results: For algorithm development, AUC for differentiation between early-stage HCC and CLD was 90.7%, 84.4%, and 77.2% for GAAD, AFP, and PIVKA-II, respectively. The sensitivity of GAAD for the detection of early-stage HCC was 71.8% with 90.0% specificity. Similar results were shown in the clinical validation study; AUC for differentiation between early-stage HCC and CLD was 91.4% with 70.1% sensitivity and 93.7% specificity. GAAD also showed strong specificity, with a lower rate of false positives regardless of disease stage, etiology, or region. Conclusions: The GAAD algorithm significantly improves early-stage HCC detection for patients with CLD undergoing HCC surveillance. Further phase III and IV studies are warranted to assess the utility of incorporating the algorithm into clinical practice.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
标致过客2025完成签到,获得积分10
刚刚
Crazy_Runner发布了新的文献求助10
刚刚
wyb发布了新的文献求助10
刚刚
Debbie的应助被leslierui采纳,获得10
刚刚
群青完成签到 ,获得积分10
刚刚
科研通AI6.2的应助被一块麻糖采纳,获得10
1秒前
安静的斑马完成签到,获得积分10
1秒前
1秒前
垦丁的海啊完成签到,获得积分10
2秒前
Shi完成签到,获得积分10
2秒前
风笛发布了新的文献求助10
2秒前
烟花的应助被qi采纳,获得10
2秒前
辛勤如柏完成签到,获得积分10
3秒前
JamesPei的应助被赵纤采纳,获得10
3秒前
云与海完成签到,获得积分10
4秒前
领导范儿的应助被美满巧凡采纳,获得10
4秒前
皮老八发布了新的文献求助10
4秒前
苏小狸完成签到,获得积分10
4秒前
5秒前
欢呼以柳完成签到,获得积分10
5秒前
5秒前
探讨完成签到,获得积分20
6秒前
6秒前
Ali完成签到,获得积分10
6秒前
Hello的应助被九万里采纳,获得10
6秒前
Questa_Qin完成签到,获得积分10
7秒前
开朗钢铁侠完成签到 ,获得积分10
7秒前
咩咩完成签到,获得积分10
8秒前
Jasper的应助被YX1994采纳,获得10
8秒前
小冯1完成签到,获得积分10
9秒前
机智的方盒完成签到 ,获得积分10
10秒前
10秒前
11秒前
molihuakai的应助被xnz采纳,获得10
11秒前
11秒前
11秒前
lyj完成签到 ,获得积分10
12秒前
小憨锅发布了新的文献求助10
12秒前
zero完成签到 ,获得积分10
12秒前
勤奋笙完成签到,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159304
求助须知:如何正确求助?哪些是违规求助? 9554712
关于积分的说明 21721292
捐赠科研通 7748946
什么是DOI,文献DOI怎么找? 3427185
关于科研通互助平台的介绍 2552123
邀请新用户注册赠送积分活动 2471484